William Blair initiated coverage of Zealand Pharma (ZLDPF) with a Market Perform rating.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- Zealand Pharma price target lowered to DKK 1,050 from DKK 1,080 at Berenberg
- Zealand Pharma’s Earnings Call: Clinical Gains and Challenges
- Zealand Pharma price target lowered to DKK 750 from DKK 755 at Morgan Stanley
- Zealand Pharma Reports Transformative Year with Strong R&D Focus
- ZLDPF Earnings this Week: How Will it Perform?